Correlation Between NRBO Old and Windtree Therapeutics
Can any of the company-specific risk be diversified away by investing in both NRBO Old and Windtree Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRBO Old and Windtree Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NRBO Old and Windtree Therapeutics, you can compare the effects of market volatilities on NRBO Old and Windtree Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRBO Old with a short position of Windtree Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRBO Old and Windtree Therapeutics.
Diversification Opportunities for NRBO Old and Windtree Therapeutics
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between NRBO and Windtree is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding NRBO Old and Windtree Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Windtree Therapeutics and NRBO Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRBO Old are associated (or correlated) with Windtree Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Windtree Therapeutics has no effect on the direction of NRBO Old i.e., NRBO Old and Windtree Therapeutics go up and down completely randomly.
Pair Corralation between NRBO Old and Windtree Therapeutics
Given the investment horizon of 90 days NRBO Old is expected to generate 0.55 times more return on investment than Windtree Therapeutics. However, NRBO Old is 1.81 times less risky than Windtree Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Windtree Therapeutics is currently generating about -0.33 per unit of risk. If you would invest 198.00 in NRBO Old on December 30, 2024 and sell it today you would lose (9.00) from holding NRBO Old or give up 4.55% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 33.87% |
Values | Daily Returns |
NRBO Old vs. Windtree Therapeutics
Performance |
Timeline |
NRBO Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Windtree Therapeutics |
NRBO Old and Windtree Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with NRBO Old and Windtree Therapeutics
The main advantage of trading using opposite NRBO Old and Windtree Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRBO Old position performs unexpectedly, Windtree Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Windtree Therapeutics will offset losses from the drop in Windtree Therapeutics' long position.NRBO Old vs. Allarity Therapeutics | NRBO Old vs. Virax Biolabs Group | NRBO Old vs. Quoin Pharmaceuticals Ltd | NRBO Old vs. Biodexa Pharmaceticals |
Windtree Therapeutics vs. Palisade Bio | Windtree Therapeutics vs. Lixte Biotechnology Holdings | Windtree Therapeutics vs. Avenue Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |